Telomerase inhibition brings metabolic compromises in glioblastoma multiforme (GBM)

被引：0
|
作者：
Ahmad, Fahim [1 ]
Sen, Ellora [1 ]
机构：
[1] Natl Brain Res Ctr, Gurgaon, Haryana, India
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.FBCR15-A08
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A08
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Bevacizumab and irinotecan in patients with recurrent glioblastoma multiforme (GBM)
    Raval, Sumul N.
    Rule, Amy
    Hwang, Shirley S.
    [J]. NEURO-ONCOLOGY, 2006, 8 (04) : 482 - 482
  • [22] The Repurposing of Ritanserin for the Inhibition of Diacylglycerol Kinase Alpha (DGKa), a Novel Therapeutic Target in Glioblastoma Multiforme (GBM)
    Boroda, Salome
    Harris, Thurl E.
    Purow, Benjamin W.
    [J]. FASEB JOURNAL, 2016, 30
  • [23] IMPACT OF GLIOBLASTOMA MULTIFORME (GBM) ON PATIENTS' QUALITY OF LIFE (QOL)
    Byrne, K.
    Waller, J.
    Piercy, J.
    Shaw, J.
    Dastani, H.
    [J]. NEURO-ONCOLOGY, 2017, 19 : 123 - 123
  • [24] Advanced biomaterials for human glioblastoma multiforme (GBM) drug delivery
    Nozhat, Zahra
    Heydarzadeh, Shabnam
    Shahriari-Khalaji, Mina
    Wang, Shibo
    Iqbal, M. Zubair
    Kong, Xiangdong
    [J]. BIOMATERIALS SCIENCE, 2023, 11 (12) : 4094 - 4131
  • [25] Is there delay in the treatment of Glioblastoma Multiforme (GBM) and does it affect prognosis?
    Darmanin, L.
    Mizzi, S.
    [J]. BRITISH JOURNAL OF SURGERY, 2018, 105 : 147 - 147
  • [26] TRAIL POTENTIATES PANOBINOSTAT CYTOTOXICITY IN GLIOBLASTOMA MULTIFORME (GBM) IN VITRO
    Darling, John L.
    Rowther, Farjana B.
    Armesilla, Angel L.
    Dawson, Timothy P.
    Ashton, Katherine
    Warr, Tracy
    [J]. NEURO-ONCOLOGY, 2014, 16
  • [27] IMPROVING THE ODDS - LONG TERM SURVIVORS OF GLIOBLASTOMA MULTIFORME (GBM)
    Akbar, Palwasha Khan
    Lord, Hannah
    [J]. NEURO-ONCOLOGY, 2022, 24 : 16 - 16
  • [28] HER-2/neu expression in glioblastoma multiforme (GBM)
    Gupta, S.
    Sheikh, H.
    Schneider, C.
    Zhang, X.
    Padmanabhan, A.
    Ali, A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [29] REAL-WORLD TREATMENT PATTERNS IN GLIOBLASTOMA MULTIFORME (GBM)
    Byrne, K.
    Waller, J.
    Piercy, J.
    Shaw, J.
    Dastani, H.
    [J]. NEURO-ONCOLOGY, 2017, 19 : 32 - 32
  • [30] Overexpression of MARCKS in EGFRvIII-expressing glioblastoma multiforme (GBM)
    Micallef, J
    Caldwell, J
    Moran, M
    Guha, A
    [J]. NEURO-ONCOLOGY, 2004, 6 (04) : 319 - 319
12345